sulfinpyrazone has been researched along with Lung Neoplasms in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oguri, T | 1 |
| Ozasa, H | 1 |
| Uemura, T | 1 |
| Bessho, Y | 1 |
| Miyazaki, M | 1 |
| Maeno, K | 1 |
| Maeda, H | 1 |
| Sato, S | 1 |
| Ueda, R | 1 |
| Zaman, GJ | 1 |
| Cnubben, NH | 1 |
| van Bladeren, PJ | 1 |
| Evers, R | 1 |
| Borst, P | 1 |
2 other studies available for sulfinpyrazone and Lung Neoplasms
| Article | Year |
|---|---|
MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Drug Resistanc | 2008 |
Transport of the glutathione conjugate of ethacrynic acid by the human multidrug resistance protein MRP.
Topics: Adenosine Monophosphate; ATP-Binding Cassette Transporters; Biological Transport; Carcinoma, Non-Sma | 1996 |